Insulet (PODD) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Powered by 
Analysis
Insulet (PODD) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28% |
| Mar 31, 2026 | -10.42% |
| Dec 31, 2025 | 16.10% |
| Sep 30, 2025 | 289.33% |
| Jun 30, 2025 | -36.62% |
| Mar 31, 2025 | -64.75% |
| Dec 31, 2024 | 29.94% |
| Sep 30, 2024 | -58.91% |
| Jun 30, 2024 | 266.21% |
| Mar 31, 2024 | -50.19% |
| Dec 31, 2023 | 99.23% |
| Sep 30, 2023 | 90.11% |
| Jun 30, 2023 | 14.71% |
| Mar 31, 2023 | 40.00% |
| Dec 31, 2022 | 426.92% |
| Sep 30, 2022 | 85.14% |
| Jun 30, 2022 | -225.90% |
| Mar 31, 2022 | -4.79% |
| Dec 31, 2021 | 131.75% |
| Sep 30, 2021 | 150.40% |